[
{
"old_id":"1",
"old_nametree":"Authors and legal information",
"old_numtree":"1.0.0.0",
"old_htmlpage":"ENAS5094_1.0.0.0",
"new_id":"1",
"new_nametree":"Authors and legal information",
"new_numtree":"1.0.0.0",
"new_htmlpage":"ENAS5094_1.0.0.0"
},
{
"old_id":"2",
"old_nametree":"Diagnosis",
"old_numtree":"2.0.0.0",
"old_htmlpage":"ENAS5094_2.0.0.0",
"new_id":"2",
"new_nametree":"Diagnosis",
"new_numtree":"2.0.0.0",
"new_htmlpage":"ENAS5094_2.0.0.0"
},
{
"old_id":"3",
"old_nametree":"Staging and risk assessment",
"old_numtree":"3.0.0.0",
"old_htmlpage":"null",
"new_id":"3",
"new_nametree":"Staging and risk assessment",
"new_numtree":"3.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"4",
"old_nametree":"Overview",
"old_numtree":"3.1.0.0",
"old_htmlpage":"ENAS5094_3.1.0.0",
"new_id":"4",
"new_nametree":"Overview",
"new_numtree":"3.1.0.0",
"new_htmlpage":"ENAS5094_3.1.0.0"
},
{
"old_id":"5",
"old_nametree":"TNM staging for urothelial carcinoma",
"old_numtree":"3.2.0.0",
"old_htmlpage":"ENAS5094_3.2.0.0",
"new_id":"5",
"new_nametree":"TNM staging for urothelial carcinoma",
"new_numtree":"3.2.0.0",
"new_htmlpage":"ENAS5094_3.2.0.0"
},
{
"old_id":"6",
"old_nametree":"Management of local/ locoregional disease",
"old_numtree":"4.0.0.0",
"old_htmlpage":"null",
"new_id":"6",
"new_nametree":"Management of local/locoregional disease",
"new_numtree":"4.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"7",
"old_nametree":"Treatment of non-muscle-invasive BC",
"old_numtree":"4.1.0.0",
"old_htmlpage":"ENAS5094_4.1.0.0",
"new_id":"7",
"new_nametree":"Treatment of non-muscle-invasive BC",
"new_numtree":"4.1.0.0",
"new_htmlpage":"ENAS5094_4.1.0.0"
},
{
"old_id":"8",
"old_nametree":"Treatment of muscle-invasive BC",
"old_numtree":"4.2.0.0",
"old_htmlpage":"ENAS5094_4.2.0.0",
"new_id":"8",
"new_nametree":"Treatment of muscle-invasive BC",
"new_numtree":"4.2.0.0",
"new_htmlpage":"ENAS5094_4.2.0.0"
},
{
"old_id":"9",
"old_nametree":"Neoadjuvant and adjuvant therapy",
"old_numtree":"4.3.0.0",
"old_htmlpage":"ENAS5094_4.3.0.0",
"new_id":"9",
"new_nametree":"Neoadjuvant and adjuvant therapy",
"new_numtree":"4.3.0.0",
"new_htmlpage":"ENAS5094_4.3.0.0"
},
{
"old_id":"10",
"old_nametree":"Organ preservation therapy",
"old_numtree":"4.4.0.0",
"old_htmlpage":"ENAS5094_4.4.0.0",
"new_id":"10",
"new_nametree":"Organ preservation therapy",
"new_numtree":"4.4.0.0",
"new_htmlpage":"ENAS5094_4.4.0.0"
},
{
"old_id":"11",
"old_nametree":"Mgmt. of advanced and metastatic disease",
"old_numtree":"5.0.0.0",
"old_htmlpage":"null",
"new_id":"11",
"new_nametree":"Mgmt. of advanced and metastatic disease",
"new_numtree":"5.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"12",
"old_nametree":"Overview",
"old_numtree":"5.1.0.0",
"old_htmlpage":"ENAS5094_5.1.0.0",
"new_id":"12",
"new_nametree":"Overview",
"new_numtree":"5.1.0.0",
"new_htmlpage":"ENAS5094_5.1.0.0"
},
{
"old_id":"13",
"old_nametree":"Treatment of relapse",
"old_numtree":"5.2.0.0",
"old_htmlpage":"ENAS5094_5.2.0.0",
"new_id":"13",
"new_nametree":"Treatment of relapse",
"new_numtree":"5.2.0.0",
"new_htmlpage":"ENAS5094_5.2.0.0"
},
{
"old_id":"14",
"old_nametree":"Clinical mgmt. of suspected BC",
"old_numtree":"6.0.0.0",
"old_htmlpage":"ENAS5094_6.0.0.0",
"new_id":"14",
"new_nametree":"Clinical mgmt. of suspected BC",
"new_numtree":"6.0.0.0",
"new_htmlpage":"ENAS5094_6.0.0.0"
},
{
"old_id":"15",
"old_nametree":"Personalised medicine",
"old_numtree":"7.0.0.0",
"old_htmlpage":"ENAS5094_7.0.0.0",
"new_id":"15",
"new_nametree":"Personalised medicine",
"new_numtree":"7.0.0.0",
"new_htmlpage":"ENAS5094_7.0.0.0"
},
{
"old_id":"16",
"old_nametree":"Follow-up and long term implications",
"old_numtree":"8.0.0.0",
"old_htmlpage":"ENAS5094_8.0.0.0",
"new_id":"16",
"new_nametree":"Follow-up and long term implications",
"new_numtree":"8.0.0.0",
"new_htmlpage":"ENAS5094_8.0.0.0"
},
{
"old_id":"17",
"old_nametree":"Summary of recommendations",
"old_numtree":"9.0.0.0",
"old_htmlpage":"null",
"new_id":"17",
"new_nametree":"Summary of recommendations",
"new_numtree":"9.0.0.0",
"new_htmlpage":"null"
},
{
"old_id":"18",
"old_nametree":"Diagnosis",
"old_numtree":"9.1.0.0",
"old_htmlpage":"ENAS5094_9.1.0.0",
"new_id":"18",
"new_nametree":"Diagnosis",
"new_numtree":"9.1.0.0",
"new_htmlpage":"ENAS5094_9.1.0.0"
},
{
"old_id":"19",
"old_nametree":"Staging and risk assessment",
"old_numtree":"9.2.0.0",
"old_htmlpage":"ENAS5094_9.2.0.0",
"new_id":"19",
"new_nametree":"Staging and risk assessment",
"new_numtree":"9.2.0.0",
"new_htmlpage":"ENAS5094_9.2.0.0"
},
{
"old_id":"20",
"old_nametree":"Management of local/ locoregional disease",
"old_numtree":"9.3.0.0",
"old_htmlpage":"null",
"new_id":"20",
"new_nametree":"Management of local/ locoregional disease",
"new_numtree":"9.3.0.0",
"new_htmlpage":"null"
},
{
"old_id":"21",
"old_nametree":"Treatment of non-muscle-invasive BC",
"old_numtree":"9.3.1.0",
"old_htmlpage":"ENAS5094_9.3.1.0",
"new_id":"21",
"new_nametree":"Treatment of non-muscle-invasive BC",
"new_numtree":"9.3.1.0",
"new_htmlpage":"ENAS5094_9.3.1.0"
},
{
"old_id":"22",
"old_nametree":"Treatment of muscle-invasive BC",
"old_numtree":"9.3.2.0",
"old_htmlpage":"ENAS5094_9.3.2.0",
"new_id":"22",
"new_nametree":"Treatment of muscle-invasive BC",
"new_numtree":"9.3.2.0",
"new_htmlpage":"ENAS5094_9.3.2.0"
},
{
"old_id":"23",
"old_nametree":"Neoadjuvant and adjuvant therapy",
"old_numtree":"9.3.3.0",
"old_htmlpage":"ENAS5094_9.3.3.0",
"new_id":"23",
"new_nametree":"Neoadjuvant and adjuvant therapy",
"new_numtree":"9.3.3.0",
"new_htmlpage":"ENAS5094_9.3.3.0"
},
{
"old_id":"24",
"old_nametree":"Organ preservation therapy",
"old_numtree":"9.3.4.0",
"old_htmlpage":"ENAS5094_9.3.4.0",
"new_id":"24",
"new_nametree":"Organ preservation therapy",
"new_numtree":"9.3.4.0",
"new_htmlpage":"ENAS5094_9.3.4.0"
},
{
"old_id":"25",
"old_nametree":"Mgmt. of advanced and metastatic disease",
"old_numtree":"9.4.0.0",
"old_htmlpage":"null",
"new_id":"25",
"new_nametree":"Mgmt. of advanced and metastatic disease",
"new_numtree":"9.4.0.0",
"new_htmlpage":"null"
},
{
"old_id":"26",
"old_nametree":"Overview",
"old_numtree":"9.4.1.0",
"old_htmlpage":"ENAS5094_2017032729",
"new_id":"26",
"new_nametree":"Overview",
"new_numtree":"9.4.1.0",
"new_htmlpage":"ENAS5094_2017032729"
},
{
"old_id":"27",
"old_nametree":"Treatment of relapse",
"old_numtree":"9.4.2.0",
"old_htmlpage":"ENAS5094_2017032730",
"new_id":"27",
"new_nametree":"Treatment of relapse",
"new_numtree":"9.4.2.0",
"new_htmlpage":"ENAS5094_2017032730"
},
{
"old_id":"28",
"old_nametree":"Personalised medicine",
"old_numtree":"9.5.0.0",
"old_htmlpage":"ENAS5094_9.5.0.0",
"new_id":"28",
"new_nametree":"Personalised medicine",
"new_numtree":"9.5.0.0",
"new_htmlpage":"ENAS5094_9.5.0.0"
},
{
"old_id":"29",
"old_nametree":"Follow-up and long term implications",
"old_numtree":"9.6.0.0",
"old_htmlpage":"ENAS5094_9.6.0.0",
"new_id":"29",
"new_nametree":"Follow-up and long term implications",
"new_numtree":"9.6.0.0",
"new_htmlpage":"ENAS5094_9.6.0.0"
},
{
"old_id":"30",
"old_nametree":"Glossary",
"old_numtree":"10.0.0.0",
"old_htmlpage":"ENAS5094_10.0.0.0",
"new_id":"30",
"new_nametree":"Glossary",
"new_numtree":"10.0.0.0",
"new_htmlpage":"ENAS5094_10.0.0.0"
}
]